F-group (family)
225.1.1.2 HSP90,HATPase_c_3
Ligands and drugs
853
Member domains
696
with ligand contacts (≤ 4 Å)
81.6% of members
578
with DrugDomain annotations
67.8% of members
293
with a DrugBank compound
34.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 225.1.1.2 belongs to X-group 225 ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase-like, which binds 9.8 ligand superclasses per 20 proteins, broader than 92% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 31 |
| DB16833 | ADP | Adenosine disphosphate | 25 |
| DB02424 | GDM | Geldanamycin | 9 |
| DB03758 | RDC | Radicicol | 8 |
| DB03719 | NEC | N-Ethyl-5'-Carboxamido Adenosine | 6 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 5 |
| DB08464 | RDA | METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE | 5 |
| DB08465 | RDE | 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE | 5 |
| DB07319 | A56 | 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE | 4 |
| DB07594 | CT5 | CCT-018159 | 4 |
| DB17055 | E0G | SNX-2112 | 4 |
| DB00173 | ADE | Adenine | 3 |
| DB02527 | CMP | Cyclic adenosine monophosphate | 3 |
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 3 |
| DB02935 | M2M | Diglyme | 3 |
| DB03148 | A12 | Adenosine 5'-methylenediphosphate | 3 |
| DB07877 | H64 | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 3 |
| DB08045 | KJ2 | 4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL | 3 |
| DB12047 | TUH | Ganetespib | 3 |
| DB12359 | 94M | BIIB021 | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 104 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 38 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 33 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 23 |
| CL | CHLORIDE ION | 13 |
| Kmetal | POTASSIUM ION | 13 |
| 42C | N,N-dimethyl-7H-purin-6-amine | 11 |
| 2GJ | 5-[2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL]-N-ETHYL-4-[4-(MORPHOLIN-4-YLMETHYL)PHENYL]ISOXAZOLE-3-CARBOXAMIDE | 9 |
| GDM | GELDANAMYCIN | 7 |
| M0U | 1-[2,4-bis(oxidanyl)-5-propan-2-yl-phenyl]-5-[4-[(cyclohexylmethylamino)methyl]phenyl]-~{N}-ethyl-1,2,3-triazole-4-carboxamide | 6 |
| RDC | RADICICOL | 6 |
| 6DL | 5-(5-Bromo-2,4-dihydroxy-phenyl)-4-(2-fluoro-phenyl)-2,4-dihydro-[1,2,4]triazol-3-one | 5 |
| 9QY | methyl 2-[2-(1-benzyl-1H-imidazol-2-yl)ethyl]-3-chloro-4,6-dihydroxybenzoate | 5 |
| AGS | PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | 5 |
| D57 | dimethyl 2-[2-(1-benzyl-1H-imidazol-2-yl)ethyl]-4,6-dihydroxybenzene-1,3-dicarboxylate | 5 |
| NEC | N-ETHYL-5'-CARBOXAMIDO ADENOSINE | 5 |
| TUH | 5-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-4-(1-methyl-1H-indol-5-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one | 5 |
| ZUY | 9-(pent-4-yn-1-yl)-8-[(2,4,6-trimethylphenyl)sulfanyl]-9H-purin-6-amine | 5 |
| 13C | (5E)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-2-BENZAZACYCLOTETRADECINE-1,11(2H,12H)-DIONE | 4 |
| 6TN | [2,4-bis(oxidanyl)-5-propan-2-yl-phenyl]-(2-ethoxy-7,8-dihydro-5~{H}-pyrido[4,3-d]pyrimidin-6-yl)methanone | 4 |